These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3141170)

  • 21. Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M
    Antimicrob Agents Chemother; 1979 Dec; 16(6):757-60. PubMed ID: 316989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Dec; 8(4):245-9. PubMed ID: 2856864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin.
    Chin NX; Yu KW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):841-6. PubMed ID: 2086221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):703-6. PubMed ID: 3486632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Sep; 24(3):375-82. PubMed ID: 6605719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
    Sanders CC
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1313-7. PubMed ID: 2802558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.
    Jorgensen JH; Redding JS; Maher LA
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1477-80. PubMed ID: 3190179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli.
    Huovinen S; Klossner ML; Katila ML; Huovinen P
    Scand J Infect Dis; 1989; 21(3):303-9. PubMed ID: 2667097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Ayers LW; Gerlach EH; Gavan TL
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):193-8. PubMed ID: 3568594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin.
    Ripa S; Prenna M
    Chemotherapy; 1979; 25(1):9-13. PubMed ID: 33784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins].
    Bedenić B; Singer S
    Lijec Vjesn; 2000; 122(1-2):8-13. PubMed ID: 10916350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.